Histamine Toxicity Market Share

  • Report ID: 5462
  • Published Date: Nov 26, 2025
  • Report Format: PDF, PPT

Histamine Toxicity Market - Regional Analysis

North American Market Insights

 North America industry is poised to account for largest revenue share of 33% by 2035, due to rising substantial consumption of seafood and canned fish in the region. North American have a growing appetite for seafood with fish consumption levels exceeding the global average. This increased consumption, particularly of canned fish and certain fish species with naturally high histamine levels directly impacts the market. According to the recently published National Fisheries Institute's Top 10 List of Seafood Consumption in 2021, Americans consumed a record twenty-five pounds of fish per capita, up 1.5 pounds from 2020. Furthermore, public awareness about histamine intolerance a condition where people struggle to metabolize histamine efficiently is on the rise. This awareness creates a demand for diagnostic tests and treatments comprising digestive diamine oxidase enzyme supplements that aid in histamine breakdown.

European Market Insights

The market in the Europe region is set to hold a significant share by the end of 2035. Due to the increased demand for frozen foods, much-canned fish is exported from Europe. The histamine toxicity market growth is to blame for all of these factors. In order to set quality standards, collaboration with the fishing community and public health authorities will be required. Besides, the European pharmaceutical and research institutions are actively engaged in developing novel treatments and diagnostics for histamine intolerance and related disorders contributing to market innovation. The availability of anti-histamines as OTC drugs in the region is also significantly driving the growth of the histamine toxicity market in the European region during the anticipated time period.

Histamine Toxicity Market Share

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2026, the industry size of histamine toxicity is estimated at USD 461.18 million.

The global histamine toxicity market size was around USD 440.18 million in 2025 and is likely to expand at a CAGR of more than 5.3%, surpassing USD 737.76 million revenue by 2035.

North America is anticipated to capture a 33% revenue share by 2035, driven by high seafood consumption and growing awareness of histamine intolerance.

Key players in the market include Travere Therapeutics, Inc., Alembic pharmaceuticals, Intas Pharmaceuticals Ltd, Sanofi Aventis Ltd, Cipla Limited, Actavis Inc.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos